ArticleCase reports in oncology

Negative Impact of Gemtuzumab Ozogamicin on CD33-Positive Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report.

Osamu Imataki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.